abstract |
The invention relates to 1,3-oxathiolane nucleosideanalogues and their use for the treatment of viral infection,especially to/-/-4-amino-5-fluorine-1-/2-hydroxymethyl-1,3-oxathiolane-5-il/-/1H-n irimidine-2-on and its pharmaceutically accepted derivatives,as well as to pharmaceutical forms containing it. |